In a recently published study, Luo et al. (2020) disclosed that NSE level was significantly associated with tumor stage, lymph node, and distant metastasis of CRC patients, suggesting that NSE could be used as a progression biomarker of CRC. This evidence concerns the gene ENO2 and neoplasm.